About 19 percent of companies with 200 or more workers, and 43 percent of firms with 5,000 or more workers, covered GLP-1 drugs for weight loss in their largest health plan in 2025, according to research from the Peterson Center on Healthcare and the Kaiser Family Foundation (KFF)
First, you might be in metabolic adaptation or starvation mode because you are eating too little , causing your body to hoard energy
If side effects are too intense, your PlexusDx provider can pause your dose escalation and keep you at your current level for additional weeks while your body fully adapts
Estimation-based protocols drift by 1020% over multi-week timelines, turning what should be controlled research into uncontrolled dosing experiments
Institutional review board permission is not required for conducting systematic review and meta-analysis